If you’re an atrial fibrillation patient who does not take an anticoagulant, you might be interested in a new class of anticoagulants currently being evaluated in a clinical trial.
Afib puts patients at an increased risk for stroke because blood may not be properly pumped out of the heart, which may cause it to pool and form a clot. This clot can then travel to the brain and block the flow of blood to part of the brain which can result in a stroke.
The LILAC – TIMI 76 trial is testing a monthly medication of a new type of anticoagulants called Factor XI (Factor Eleven) inhibitors. Factor XI inhibitors are expected to cause significantly less bleeding than currently available blood thinners while still protecting from harmful blood clots.
- This clinical trial is recruiting afib patients who are age 65 years or over and are not appropriate for currently available blood thinners (as determined by your doctor).
- If you have afib but have never taken a blood thinner, or stopped taking a blood thinner more than 60 days ago, you may be eligible to participate.
- An initial screening period with tests, assessments, and questionnaires will be done to determine if this trial is right for you. The trial is expected to last for about 18 months (1.5 years) for each participant.
To learn more and find information to discuss with your doctor, please visit: lilactrialinfo.com
